SUCLG2
Basic information
Region (hg38): 3:67360460-67654612
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SUCLG2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | 18 | ||||
missense | 63 | 73 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 5 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 4 | 2 | 7 | ||
non coding | 16 | 24 | ||||
Total | 0 | 0 | 70 | 37 | 16 |
Variants in SUCLG2
This is a list of pathogenic ClinVar variants found in the SUCLG2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-67360640-A-G | Uncertain significance (Jul 19, 2022) | |||
3-67360675-G-A | Uncertain significance (Jan 10, 2024) | |||
3-67360676-C-T | Uncertain significance (Jun 11, 2022) | |||
3-67360679-C-T | not specified | Benign (Feb 01, 2024) | ||
3-67360689-G-T | Likely benign (Jul 31, 2023) | |||
3-67360707-A-T | SUCLG2-related disorder | Uncertain significance (Jan 29, 2024) | ||
3-67360719-T-C | Likely benign (Dec 12, 2023) | |||
3-67360738-A-G | Uncertain significance (Nov 04, 2021) | |||
3-67360742-A-G | not specified | Benign (Feb 01, 2024) | ||
3-67360748-CT-C | Benign (Jan 22, 2024) | |||
3-67375857-T-C | SUCLG2-related disorder | Benign (Jul 08, 2019) | ||
3-67375866-G-A | SUCLG2-related disorder | Benign (Sep 12, 2019) | ||
3-67375869-G-A | SUCLG2-related disorder | Likely benign (Oct 03, 2019) | ||
3-67400711-G-A | Benign (Jan 22, 2024) | |||
3-67400739-C-T | Uncertain significance (Jan 20, 2024) | |||
3-67400752-G-C | not specified | Uncertain significance (May 06, 2022) | ||
3-67400764-C-T | not specified | Uncertain significance (Apr 17, 2024) | ||
3-67400772-C-T | Likely benign (Aug 04, 2023) | |||
3-67400773-G-A | not specified | Benign (Feb 01, 2024) | ||
3-67400793-T-C | Uncertain significance (Jan 15, 2022) | |||
3-67400794-T-G | Uncertain significance (Jan 04, 2024) | |||
3-67400808-C-A | not specified | Uncertain significance (Aug 10, 2021) | ||
3-67400815-C-T | not specified | Uncertain significance (Mar 20, 2023) | ||
3-67400816-G-A | Likely benign (Jul 13, 2022) | |||
3-67400818-T-C | not specified | Uncertain significance (Feb 03, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SUCLG2 | protein_coding | protein_coding | ENST00000493112 | 11 | 294155 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
5.72e-14 | 0.0153 | 124715 | 1 | 78 | 124794 | 0.000317 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.488 | 244 | 223 | 1.09 | 0.0000114 | 2860 |
Missense in Polyphen | 94 | 84.926 | 1.1069 | 1013 | ||
Synonymous | 0.182 | 82 | 84.1 | 0.975 | 0.00000476 | 850 |
Loss of Function | -0.129 | 20 | 19.4 | 1.03 | 9.06e-7 | 251 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00105 | 0.00105 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000334 | 0.000334 |
Finnish | 0.000186 | 0.000186 |
European (Non-Finnish) | 0.000178 | 0.000168 |
Middle Eastern | 0.000334 | 0.000334 |
South Asian | 0.000643 | 0.000588 |
Other | 0.000168 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: GTP-specific succinyl-CoA synthetase functions in the citric acid cycle (TCA), coupling the hydrolysis of succinyl-CoA to the synthesis of GTP and thus represents the only step of substrate-level phosphorylation in the TCA. The beta subunit provides nucleotide specificity of the enzyme and binds the substrate succinate, while the binding sites for coenzyme A and phosphate are found in the alpha subunit. {ECO:0000255|HAMAP- Rule:MF_03221}.;
- Pathway
- Citrate cycle (TCA cycle) - Homo sapiens (human);Propanoate metabolism - Homo sapiens (human);Valproic Acid Pathway, Pharmacodynamics;Pathway_PA165964473;Warburg Effect;The oncogenic action of Succinate;The oncogenic action of Fumarate;Pyruvate dehydrogenase deficiency (E3);Pyruvate dehydrogenase deficiency (E2);2-ketoglutarate dehydrogenase complex deficiency;Mitochondrial complex II deficiency;Fumarase deficiency;Congenital lactic acidosis;Citric Acid Cycle;Glutaminolysis and Cancer;The oncogenic action of 2-hydroxyglutarate;The oncogenic action of L-2-hydroxyglutarate in Hydroxygluaricaciduria;The oncogenic action of D-2-hydroxyglutarate in Hydroxygluaricaciduria ;miR-targeted genes in lymphocytes - TarBase;TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc);TCA Cycle;Citrate cycle;Citric acid cycle (TCA cycle);Pyruvate metabolism and Citric Acid (TCA) cycle;The citric acid (TCA) cycle and respiratory electron transport;Metabolism;TCA cycle;TCA cycle;superpathway of conversion of glucose to acetyl CoA and entry into the TCA cycle
(Consensus)
Recessive Scores
- pRec
- 0.498
Intolerance Scores
- loftool
- 0.900
- rvis_EVS
- 0.62
- rvis_percentile_EVS
- 83.36
Haploinsufficiency Scores
- pHI
- 0.232
- hipred
- N
- hipred_score
- 0.389
- ghis
- 0.497
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.652
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Suclg2
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- tricarboxylic acid cycle;succinyl-CoA metabolic process;succinate metabolic process
- Cellular component
- mitochondrion;mitochondrial matrix;plasma membrane;succinate-CoA ligase complex (GDP-forming)
- Molecular function
- magnesium ion binding;succinate-CoA ligase (ADP-forming) activity;succinate-CoA ligase (GDP-forming) activity;protein binding;ATP binding;GTP binding;GDP binding;protein heterodimerization activity